Monogenic Diabetes

Gene: DYRK1B

Amber List (moderate evidence)

DYRK1B (dual specificity tyrosine phosphorylation regulated kinase 1B)
EnsemblGeneIds (GRCh38): ENSG00000105204
EnsemblGeneIds (GRCh37): ENSG00000105204
OMIM: 604556, Gene2Phenotype
DYRK1B is in 2 panels

1 review

Krithika Murali (Victorian Clinical Genetics Services)

I don't know

Have reviewed as Amber based on metabolic syndrome phenotype having a significant polygenic contribution, prevalence of reported variants in healthy population databases and inconclusive functional evidence.

PMID 24827035 Keramati et al 2014 NEJM - first reported a heterozygous DYRK1B founder variant (R102C) in 3 Iranian families with early-onset features of metabolic syndrome (central obesity, coronary artery disease, T2DM, hypertension, hypertriglyceridemia). Variant identified by WES and co-segregated with this phenotype in the family. Variant present in gnomad (v2) - 4 hets (European Non-Finnish), 40-45 yo age group. The authors also screened a cohort of 300 morbidly obese Caucasian individuals for this variant and identified heterozygous H90C variant (same exon) in 5 individuals. These individuals also had features of early-onset metabolic syndrome with variant reported to co-segregate with this phenotype in the family. This variant is absent from gnomAD. Functional studies in this study and PMID 28743892 have been inconclusive in clarifying the gene disease mechanism for this variant.

PMID 34193236 Mendoza-Caamal et al 2021 - report 2 unrelated families with heterozygous variants in this gene co-segregating with early-onset metabolic syndrome phenotype. p.Arg252His variant present in 8 hets in gnomAD and p.Lys68Gln in 5 hets.

PMID 34786696 Orenstein et al 2022 report a family with DYRK1B PTC variant associated with metabolic syndrome and abnormal cognition - unable to access this article.
Created: 4 May 2022, 2:02 a.m. | Last Modified: 4 May 2022, 2:02 a.m.
Panel Version: 0.23

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Abdominal obesity-metabolic syndrome 3 - MIM#615812

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • NHS GMS
Phenotypes
  • Metabolic syndrome (coronary artery disease, hypertension, central obesity and diabetes)
  • Abdominal obesity-metabolic syndrome 3, 615812
OMIM
604556
Clinvar variants
Variants in DYRK1B
Penetrance
None
Publications
Panels with this gene

History Filter Activity

5 May 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: dyrk1b has been classified as Amber List (Moderate Evidence).

5 May 2022, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: DYRK1B were set to

5 May 2022, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: DYRK1B was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

5 May 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: dyrk1b has been classified as Amber List (Moderate Evidence).

17 Jan 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: DYRK1B was added gene: DYRK1B was added to Monogenic diabetes. Sources: Expert Review Green,NHS GMS Mode of inheritance for gene: DYRK1B was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Phenotypes for gene: DYRK1B were set to Metabolic syndrome (coronary artery disease, hypertension, central obesity and diabetes); Abdominal obesity-metabolic syndrome 3, 615812